Review




Structured Review

Bayer AG pf1022a
Pf1022a, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pf1022a/product/Bayer AG
Average 90 stars, based on 1 article reviews
pf1022a - by Bioz Stars, 2026-02
90/100 stars

Images



Similar Products

90
MedChemExpress pf1022a
Stimulatory effect of BRV on the activity of the large-conductance Ca 2+ -activated K + (BK Ca ) channels in GH 3 cells. In this set of inside-out current recordings, the cells were immersed in a high-K + solution containing 1 µM Ca 2+ , where the holding potential was clamped at +60 mV. ( A ) Representative BK Ca -channel traces (blue color) obtained in the control (i.e., BRV was not present) (left side of the figure) and after the bath addition of 10 µM of BRV (right side of the figure). It should be noted that the upward deflection shows the channel opening event. The lower part (red color) of the figure shows the expanded records taken from the uppermost part of the figure; ( B ) Summary bar graph showing the open-state likelihood of the presence of BK Ca channels in the presence of BRV (10 µM), BRV (10 µM) plus TRAM39 (3 µM), BRV (10 µM) plus GAL-021 (3 µM), and BRV (10 µM) plus <t>PF1022A</t> (3 µM) (mean ± SEM; n = 7–8). The channel activity was measured when the membrane patch was maintained at +60 mV. * Significantly different from the control ( p < 0.05) and Ɨ significantly different from the 10 µM BRV-alone group ( p < 0.05).
Pf1022a, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pf1022a/product/MedChemExpress
Average 90 stars, based on 1 article reviews
pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Meiji Seika Pharma Co Ltd pf1022a
Stimulatory effect of BRV on the activity of the large-conductance Ca 2+ -activated K + (BK Ca ) channels in GH 3 cells. In this set of inside-out current recordings, the cells were immersed in a high-K + solution containing 1 µM Ca 2+ , where the holding potential was clamped at +60 mV. ( A ) Representative BK Ca -channel traces (blue color) obtained in the control (i.e., BRV was not present) (left side of the figure) and after the bath addition of 10 µM of BRV (right side of the figure). It should be noted that the upward deflection shows the channel opening event. The lower part (red color) of the figure shows the expanded records taken from the uppermost part of the figure; ( B ) Summary bar graph showing the open-state likelihood of the presence of BK Ca channels in the presence of BRV (10 µM), BRV (10 µM) plus TRAM39 (3 µM), BRV (10 µM) plus GAL-021 (3 µM), and BRV (10 µM) plus <t>PF1022A</t> (3 µM) (mean ± SEM; n = 7–8). The channel activity was measured when the membrane patch was maintained at +60 mV. * Significantly different from the control ( p < 0.05) and Ɨ significantly different from the 10 µM BRV-alone group ( p < 0.05).
Pf1022a, supplied by Meiji Seika Pharma Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pf1022a/product/Meiji Seika Pharma Co Ltd
Average 90 stars, based on 1 article reviews
pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Meiji Seika Pharma Co Ltd pf1022a 1992
Stimulatory effect of BRV on the activity of the large-conductance Ca 2+ -activated K + (BK Ca ) channels in GH 3 cells. In this set of inside-out current recordings, the cells were immersed in a high-K + solution containing 1 µM Ca 2+ , where the holding potential was clamped at +60 mV. ( A ) Representative BK Ca -channel traces (blue color) obtained in the control (i.e., BRV was not present) (left side of the figure) and after the bath addition of 10 µM of BRV (right side of the figure). It should be noted that the upward deflection shows the channel opening event. The lower part (red color) of the figure shows the expanded records taken from the uppermost part of the figure; ( B ) Summary bar graph showing the open-state likelihood of the presence of BK Ca channels in the presence of BRV (10 µM), BRV (10 µM) plus TRAM39 (3 µM), BRV (10 µM) plus GAL-021 (3 µM), and BRV (10 µM) plus <t>PF1022A</t> (3 µM) (mean ± SEM; n = 7–8). The channel activity was measured when the membrane patch was maintained at +60 mV. * Significantly different from the control ( p < 0.05) and Ɨ significantly different from the 10 µM BRV-alone group ( p < 0.05).
Pf1022a 1992, supplied by Meiji Seika Pharma Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pf1022a 1992/product/Meiji Seika Pharma Co Ltd
Average 90 stars, based on 1 article reviews
pf1022a 1992 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Fujisawa Pharmaceutical Co Ltd bis-morpholino derivative of pf1022a
Chemical structures of the semisynthetic emodepside (A) and its precursor <t>PF1022A</t> (B) purified from Rosellinia spp. PF1022.
Bis Morpholino Derivative Of Pf1022a, supplied by Fujisawa Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bis-morpholino derivative of pf1022a/product/Fujisawa Pharmaceutical Co Ltd
Average 90 stars, based on 1 article reviews
bis-morpholino derivative of pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Fujisawa Pharmaceutical Co Ltd bis-[(r)-( para-morpholino-phenyl)-lactic acid] derivative of pf1022a
Chemical structures of the semisynthetic emodepside (A) and its precursor <t>PF1022A</t> (B) purified from Rosellinia spp. PF1022.
Bis [(R) ( Para Morpholino Phenyl) Lactic Acid] Derivative Of Pf1022a, supplied by Fujisawa Pharmaceutical Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bis-[(r)-( para-morpholino-phenyl)-lactic acid] derivative of pf1022a/product/Fujisawa Pharmaceutical Co Ltd
Average 90 stars, based on 1 article reviews
bis-[(r)-( para-morpholino-phenyl)-lactic acid] derivative of pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Chemie GmbH pf1022a
Chemical structures of the semisynthetic emodepside (A) and its precursor <t>PF1022A</t> (B) purified from Rosellinia spp. PF1022.
Pf1022a, supplied by Chemie GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pf1022a/product/Chemie GmbH
Average 90 stars, based on 1 article reviews
pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Bayer AG pf1022a
Chemical structures of the semisynthetic emodepside (A) and its precursor <t>PF1022A</t> (B) purified from Rosellinia spp. PF1022.
Pf1022a, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pf1022a/product/Bayer AG
Average 90 stars, based on 1 article reviews
pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Meiji Seika Pharma Co Ltd natural product pf1022a
Chemical structures of the semisynthetic emodepside (A) and its precursor <t>PF1022A</t> (B) purified from Rosellinia spp. PF1022.
Natural Product Pf1022a, supplied by Meiji Seika Pharma Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/natural product pf1022a/product/Meiji Seika Pharma Co Ltd
Average 90 stars, based on 1 article reviews
natural product pf1022a - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Stimulatory effect of BRV on the activity of the large-conductance Ca 2+ -activated K + (BK Ca ) channels in GH 3 cells. In this set of inside-out current recordings, the cells were immersed in a high-K + solution containing 1 µM Ca 2+ , where the holding potential was clamped at +60 mV. ( A ) Representative BK Ca -channel traces (blue color) obtained in the control (i.e., BRV was not present) (left side of the figure) and after the bath addition of 10 µM of BRV (right side of the figure). It should be noted that the upward deflection shows the channel opening event. The lower part (red color) of the figure shows the expanded records taken from the uppermost part of the figure; ( B ) Summary bar graph showing the open-state likelihood of the presence of BK Ca channels in the presence of BRV (10 µM), BRV (10 µM) plus TRAM39 (3 µM), BRV (10 µM) plus GAL-021 (3 µM), and BRV (10 µM) plus PF1022A (3 µM) (mean ± SEM; n = 7–8). The channel activity was measured when the membrane patch was maintained at +60 mV. * Significantly different from the control ( p < 0.05) and Ɨ significantly different from the 10 µM BRV-alone group ( p < 0.05).

Journal: Biomedicines

Article Title: The Integrated Effects of Brivaracetam, a Selective Analog of Levetiracetam, on Ionic Currents and Neuronal Excitability

doi: 10.3390/biomedicines9040369

Figure Lengend Snippet: Stimulatory effect of BRV on the activity of the large-conductance Ca 2+ -activated K + (BK Ca ) channels in GH 3 cells. In this set of inside-out current recordings, the cells were immersed in a high-K + solution containing 1 µM Ca 2+ , where the holding potential was clamped at +60 mV. ( A ) Representative BK Ca -channel traces (blue color) obtained in the control (i.e., BRV was not present) (left side of the figure) and after the bath addition of 10 µM of BRV (right side of the figure). It should be noted that the upward deflection shows the channel opening event. The lower part (red color) of the figure shows the expanded records taken from the uppermost part of the figure; ( B ) Summary bar graph showing the open-state likelihood of the presence of BK Ca channels in the presence of BRV (10 µM), BRV (10 µM) plus TRAM39 (3 µM), BRV (10 µM) plus GAL-021 (3 µM), and BRV (10 µM) plus PF1022A (3 µM) (mean ± SEM; n = 7–8). The channel activity was measured when the membrane patch was maintained at +60 mV. * Significantly different from the control ( p < 0.05) and Ɨ significantly different from the 10 µM BRV-alone group ( p < 0.05).

Article Snippet: GAL-021 and PF1022A were acquired from MedChemExpress (Everything Biotech, New Taipei City, Taiwan); cilobradine was obtained from Cayman (Excel Biomedical, Taipei, Taiwan); 2-chloro-α, α-diphenylbenzeneacetonitrile (TRAM39) was obtained from Tocris (Union Biomed Inc., Taipei, Taiwan), and tefluthrhin, tetraethylammonium chloride and tetrodotoxin were obtained from Sigma-Aldrich (Merck Ltd., Taipei, Taiwan).

Techniques: Activity Assay, Control, Membrane

Chemical structures of the semisynthetic emodepside (A) and its precursor PF1022A (B) purified from Rosellinia spp. PF1022.

Journal: PLoS Pathogens

Article Title: Development of emodepside as a possible adulticidal treatment for human onchocerciasis—The fruit of a successful industrial–academic collaboration

doi: 10.1371/journal.ppat.1009682

Figure Lengend Snippet: Chemical structures of the semisynthetic emodepside (A) and its precursor PF1022A (B) purified from Rosellinia spp. PF1022.

Article Snippet: A patent application was subsequently filed by Fujisawa Pharmaceutical for a bis-morpholino derivative of PF1022A, which was later named emodepside [ ].

Techniques: Purification